Market Research Report

A quick peek into the report

Global Non-Invasive Liquid Biopsy Market

Focus on Offering, Sample, Application, Technology, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2021-2031

Some Faq's

Frequently Asked Questions

The global non-invasive liquid biopsy market was estimated at $1.48 Billion in 2021 and is expected to grow at a CAGR of 20.38% during the forecast period.
Opportunities that can boost the growth of the market amalgamation of artificial intelligence (AI) with non-invasive liquid biopsy and massive scope for the adoption of non-invasive liquid biopsy tests in the emerging markets.
Factors driving the growth of the market, include global increase in cancer prevalence and increasing government funding for healthcare.
Applications for which non-invasive liquid biopsy can be used include oncology, reproductive health, metabolic disorders, and other applications.
Bio-Techne Corporation, Endress + Hauser Group, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp, Nucleix Ltd., Oasis Diagnostics Corporation, OraSure Technologies, Inc., PerkinElmer Inc., Predicine, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Zymo Research Corporation.
Similar Product

You may also like

Liquid Biopsy Market - A Global and Regional Analysis
Published Year: 2022

Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Usage, Workflow, Circulati

The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2...

Global Minimally Invasive Biopsy Technologies Market
Published Year: 2020

Global Minimally Invasive Biopsy Technologies Market: Focus on Liquid Biopsy, Optical Biopsy, and Br

The minimally invasive biopsy technologies market industry analysis by BIS Research projects...